Search

Synthesis and Accumulation of Aromatic Aldehydes in an Engineered Strain of Escherichia coli

메타 데이터

바이오화학분류
    • 바이오플라스틱
      1. 고무
      2. 플라스틱
    • 바이오정밀화학
      1. 화학제품
    • 화장품용 기능성소재
      1. 기능성
    • 의료용 화학소재
      1. 건강보조식품
      2. 식품첨가제
논문

Synthesis and Accumulation of Aromatic Aldehydes in an Engineered Strain of Escherichia coli

학술지

Journal of the American Chemical Society

저자명

Kunjapur, Aditya M.; Tarasova, Yekaterina; Prather, Kristala L. J.

초록

<P>Aromatic aldehydes are useful in numerous applications, especially as flavors, fragrances, and pharmaceutical precursors. However, microbial synthesis of aldehydes is hindered by rapid, endogenous, and redundant conversion of aldehydes to their corresponding alcohols. We report the construction of an <I>Escherichia coli</I> K-12 MG1655 strain with <U>r</U>educed aromatic <U>a</U>ldehyde <U>re</U>duction (RARE) that serves as a platform for aromatic aldehyde biosynthesis. Six genes with reported activity on the model substrate benzaldehyde were rationally targeted for deletion: three genes that encode aldo-keto reductases and three genes that encode alcohol dehydrogenases. Upon expression of a recombinant carboxylic acid reductase in the RARE strain and addition of benzoate during growth, benzaldehyde remained in the culture after 24 h, with less than 12% conversion of benzaldehyde to benzyl alcohol. Although individual overexpression results demonstrated that all six genes could contribute to benzaldehyde reduction <I>in vivo</I>, additional experiments featuring subset deletion strains revealed that two of the gene deletions were dispensable under the conditions tested. The engineered strain was next investigated for the production of vanillin from vanillate and succeeded in preventing formation of the byproduct vanillyl alcohol. A pathway for the biosynthesis of vanillin directly from glucose was introduced and resulted in a 55-fold improvement in vanillin titer when using the RARE strain versus the wild-type strain. Finally, synthesis of the chiral pharmaceutical intermediate <SMALL>l</SMALL>-phenylacetylcarbinol (<SMALL>l</SMALL>-PAC) was demonstrated from benzaldehyde and glucose upon expression of a recombinant mutant pyruvate decarboxylase in the RARE strain. Beyond allowing accumulation of aromatic aldehydes as end products in <I>E. coli</I>, the RARE strain expands the classes of chemicals that can be produced microbially via aldehyde intermediates.</P><P><B>Graphic Abstract</B><BR><IMG SRC='http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/jacsat/2014/jacsat.2014.136.issue-33/ja506664a/production/images/medium/ja-2014-06664a_0005.gif'></P><P><A href='http://pubs.acs.org/doi/suppl/10.1021/ja506664a'>ACS Electronic Supporting Info</A></P>

발행연도

2014

발행기관

American Chemical Society

ISSN

0002-7863

ISSN

1520-5126

136

33

페이지

pp.11644-11654

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

1건의 후보군 물질이 있습니다.

논문; 2014-12-31

Export

About

Search

Trend